Pfizer (PFE) is a publicly traded Healthcare sector company. As of July 16, 2026, PFE trades at $24.80 with a market cap of $138.21B and a P/E ratio of 18.86. PFE moved +2.26% today. Year to date, PFE is -0.32%; over the trailing twelve months it is +0.85%. Its 52-week range spans $20.92 to $28.75. Analyst consensus is neutral with an average price target of $28.68. Rallies surfaces PFE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest PFE news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $24.80 |
| Market Cap | $138.21B |
| P/E Ratio | 18.86 |
| EPS | $1.31 |
| Dividend Yield | 0.43% |
| 52-Week High | $28.75 |
| 52-Week Low | $20.92 |
| Volume | 32.02M |
| Avg Volume | 0 |
| Revenue (TTM) | $63.31B |
| Net Income | $7.53B |
| Gross Margin | 73.51% |
23 analysts cover PFE: 0 strong buy, 7 buy, 14 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $28.68.